David Zucman

4.2k total citations
71 papers, 1.3k citations indexed

About

David Zucman is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, David Zucman has authored 71 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 32 papers in Epidemiology and 22 papers in Virology. Recurrent topics in David Zucman's work include HIV/AIDS Research and Interventions (25 papers), HIV/AIDS drug development and treatment (20 papers) and HIV Research and Treatment (20 papers). David Zucman is often cited by papers focused on HIV/AIDS Research and Interventions (25 papers), HIV/AIDS drug development and treatment (20 papers) and HIV Research and Treatment (20 papers). David Zucman collaborates with scholars based in France, United States and Belgium. David Zucman's co-authors include C. Majerholc, Sophie Caillat‐Zucman, Erwan Fourn, Alexandre Vallée, Pierre de Truchis, Gilles Peytavin, Dominique Salmon‐Céron, Daniel Vittecoq, Ingrid Jung‐Testas and E.E. Baulieu and has published in prestigious journals such as PLoS ONE, Diabetes Care and Clinical Infectious Diseases.

In The Last Decade

David Zucman

69 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Zucman France 18 589 369 301 205 165 71 1.3k
Linda Wittkop France 19 499 0.8× 331 0.9× 270 0.9× 187 0.9× 110 0.7× 80 1.2k
Cecilia T. Costiniuk Canada 24 531 0.9× 445 1.2× 576 1.9× 116 0.6× 244 1.5× 100 1.8k
Jacqueline Astemborski United States 21 668 1.1× 816 2.2× 371 1.2× 130 0.6× 134 0.8× 30 1.7k
Braden Hale United States 20 715 1.2× 698 1.9× 383 1.3× 317 1.5× 247 1.5× 52 1.7k
Michael F. Para United States 21 1.3k 2.2× 531 1.4× 1.0k 3.3× 67 0.3× 411 2.5× 55 2.0k
Pei‐Ying Wu Taiwan 21 413 0.7× 333 0.9× 189 0.6× 98 0.5× 164 1.0× 76 1.2k
Norbert Gilmore Canada 20 645 1.1× 350 0.9× 416 1.4× 48 0.2× 186 1.1× 65 1.9k
Markus Bickel Germany 25 1.1k 1.9× 691 1.9× 657 2.2× 154 0.8× 638 3.9× 73 1.9k
Yang Han China 23 1.2k 2.1× 376 1.0× 487 1.6× 160 0.8× 273 1.7× 104 1.8k
Xun Zhuang China 23 697 1.2× 899 2.4× 192 0.6× 91 0.4× 30 0.2× 91 2.0k

Countries citing papers authored by David Zucman

Since Specialization
Citations

This map shows the geographic impact of David Zucman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Zucman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Zucman more than expected).

Fields of papers citing papers by David Zucman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Zucman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Zucman. The network helps show where David Zucman may publish in the future.

Co-authorship network of co-authors of David Zucman

This figure shows the co-authorship network connecting the top 25 collaborators of David Zucman. A scholar is included among the top collaborators of David Zucman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Zucman. David Zucman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Duracinský, Martin, Issifou Yaya, Frédérique Thonon, et al.. (2024). Development of a risk prediction score for screening for HBV, HCV and HIV among migrants in France: results from a multicentre observational study (STRADA study). BMJ Open. 14(6). e075315–e075315. 2 indexed citations
3.
Farfour, Éric, et al.. (2024). Comparison of the Alinity M STI with the GeneXpert CT/NG for the detection of sexually transmitted microorganisms. Diagnostic Microbiology and Infectious Disease. 108(3). 116179–116179. 3 indexed citations
4.
Vallée, Alexandre, Julie Trichereau, Erwan Fourn, et al.. (2022). Electronic medical record alert increases HIV screening rates: the Foch hospital pilot POP-up project. BMC Health Services Research. 22(1). 784–784. 1 indexed citations
5.
6.
Wittkop, Linda, Firouzé Bani‐Sadr, Karine Lacombe, et al.. (2021). Risk of severe clinical events after sustained virological response following direct‐acting antiviral therapy in HIV and hepatitis C virus coinfected participants. HIV Medicine. 22(9). 791–804. 3 indexed citations
7.
Farfour, Éric, Olivier Chassany, S. Fouéré, et al.. (2021). Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening. PLoS ONE. 16(6). e0250557–e0250557. 9 indexed citations
8.
Vallée, Alexandre, Brigitte Bonan, Philippe Lesprit, et al.. (2021). Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign. Public Health. 196. 135–137. 10 indexed citations
9.
Rodríguez-Centeno, Javier, Assia Samri, Julià Blanco, et al.. (2020). Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1–positive individuals. PLoS ONE. 15(4). e0230772–e0230772. 8 indexed citations
10.
Jacomet, Christine, Dilek Çoban, Céline Lambert, et al.. (2017). The persons living with HIV and their pharmacists: two face-to-face surveys 2016-2017. Journal de Pharmacie Clinique. 36(4). 227–238. 1 indexed citations
11.
Carrieri, Patrizia, Camélia Protopopescu, Fabienne Marcellin, et al.. (2017). Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients. Journal of Hepatology. 67(6). 1157–1167. 18 indexed citations
12.
Farfour, Éric, C. Majerholc, Erwan Fourn, et al.. (2017). Increase in sexually transmitted infections in a cohort of outpatient HIV-positive men who have sex with men in the Parisian region. Médecine et Maladies Infectieuses. 47(7). 490–493. 7 indexed citations
13.
Rouveix, É., E. Mortier, Alain Beauchet, et al.. (2016). Analyse des motivations du choix des antirétroviraux (ARV) prescrits chez des patients infectés par le VIH (PVVIH) naïfs. La Revue de Médecine Interne. 37(12). 796–801. 4 indexed citations
14.
Piroth, Lionel, Odile Launay, Marie‐Louise Michel, et al.. (2016). Vaccination Against Hepatitis B Virus (HBV) in HIV-1–Infected Patients With Isolated Anti–HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study. The Journal of Infectious Diseases. 213(11). 1735–1742. 23 indexed citations
15.
Frange, Pierre, Laurence Meyer, Matthieu Jung, et al.. (2013). Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner. PLoS ONE. 8(7). e69144–e69144. 14 indexed citations
16.
Prazuck, Thiérry, et al.. (2013). Long-Term HIV-1 Virologic Control in Patients on a Dual NRTI Regimen. HIV Clinical Trials. 14(3). 120–126. 4 indexed citations
17.
Dupuy, Stéphanie, Marion Lambert, David Zucman, et al.. (2012). Human Herpesvirus 8 (HHV8) Sequentially Shapes the NK Cell Repertoire during the Course of Asymptomatic Infection and Kaposi Sarcoma. PLoS Pathogens. 8(1). e1002486–e1002486. 46 indexed citations
18.
Boufassa, Faroudy, Asier Sáez‐Cirión, David Zucman, et al.. (2011). CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory. PLoS ONE. 6(4). e18726–e18726. 42 indexed citations
19.
Couzigou, C., Michel Daudon, J.‐L. Meynard, et al.. (2007). Urolithiasis in HIV-Positive Patients Treated with Atazanavir. Clinical Infectious Diseases. 45(8). e105–e108. 69 indexed citations
20.
Aaron, Laurent, Jean‐Emmanuel Kahn, A. Therby, et al.. (2003). Maladie de Castleman HHV 8 positive et neutropénie auto-immune chez 2 patients infectés par le VIH. La Revue de Médecine Interne. 24(11). 748–752. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Wittkop Breakdown of academic impact, for papers by Cecilia T. Costiniuk Breakdown of academic impact, for papers by Jacqueline Astemborski Breakdown of academic impact, for papers by Braden Hale Breakdown of academic impact, for papers by Michael F. Para Breakdown of academic impact, for papers by Pei‐Ying Wu Breakdown of academic impact, for papers by Norbert Gilmore Breakdown of academic impact, for papers by Markus Bickel Breakdown of academic impact, for papers by Yang Han Breakdown of academic impact, for papers by Xun Zhuang
Rankless by CCL
2026